# Nautilus Biotechnology, Inc.: Form SCHEDULE 13D/A, filed Sep 11, 2026

- Company: [Nautilus Biotechnology, Inc.](/companies/naut.md) (CIK 1808805)
- Form: SCHEDULE 13D/A
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 11, 2026, 17:08 ET
- Period: not reported
- Accession: 0001231919-26-001165
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1808805/000123191926001165/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808805/000123191926001165/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808805/000123191926001165/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001231919-26-001165. Last ingested by Listed: Nov 3, 2026, 18:40 ET. No prices; not investment advice.